Clinical Trials

Showing trials with last updates posted in 2026.

NCT06001788 | RECRUITING | PHASE1
171 participants

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2024-02-22
Completion:
2026-12-31
Conditions
  • AML
  • AML With Mutated NPM1
  • Hematologic Malignancy
  • KMT2Ar
  • NPM1 Mutation
  • MLL Rearrangement
  • Leukemia
  • Acute Myeloid Leukemia
  • Leukemia, Myeloid
  • Leukemia, Myeloid, Acute
  • Acute Leukemia
  • Neoplasms by Histologic Type
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT05993234 | ACTIVE_NOT_RECRUITING
257 participants

A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-20
Start Date:
2023-12-05
Completion:
2026-12-01
Conditions
  • HER2-positive Advanced Gastric Cancer
  • HER2-positive Gastroesophageal Junction Adenocarcinoma
Interventions
  • DRUG
No Results Yet
NCT05929352 | COMPLETED | NA
135 participants

Song-making In a Group (SING)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2022-10-14
Completion:
2025-11-25
Conditions
  • Schizophrenia
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page